Publication | Open Access

Determining the Repertoire of IGH Gene Rearrangements to Develop Molecular Markers for Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia

Hematological MalignancyLymphoid NeoplasiaMolecular MarkersMixed-phenotype Acute LeukemiaGeneticsMalignant Blood DisorderImmunologyHematologyMolecular GeneticsGenomicsAdult T-cell Leukemia-lymphomaMedicineFunctional GenomicsMinimal Residual DiseaseIgh Gene Rearrangements